DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreen Co. (“Walgreens”, or the “Company”), America’s leading independent retail pharmacy, announced today that it is now operating as a private standalone company following its acquisition by Sycamore Partners (“Sycamore”), a leading private equity firm based in New York. Sycamore is acquiring the business in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in Walgreens, demonstrating their ongoing support and conf
Related Questions
How will the privatization affect Walgreens' valuation and potential exit opportunities for current shareholders?
What financing terms and valuation multiples were applied in the Sycamore Partners acquisition, and how do they compare to recent pharmacy sector deals?
What operational synergies or strategic shifts are expected under the new private ownership, and how might they impact cash flow, dividend policy, and long‑term growth?